A carregar...
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma
BACKGROUND: Osteosarcoma is the most common malignant solid tumor that affects bones, however, survival rates of patients with relapsed osteosarcoma have not improved in the last 30 years. Oncolytic virotherapy, which uses viruses designed to selectively replicate in cancer cells, has emerged as a p...
Na minha lista:
| Publicado no: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7978281/ https://ncbi.nlm.nih.gov/pubmed/33737338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001703 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|